<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#Cover" roleURI="http://cocrystalpharma.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#BalanceSheets" roleURI="http://cocrystalpharma.com/role/BalanceSheets" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#BalanceSheetsParenthetical" roleURI="http://cocrystalpharma.com/role/BalanceSheetsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#StatementsOfOperations" roleURI="http://cocrystalpharma.com/role/StatementsOfOperations" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#StatementsOfStockholdersEquity" roleURI="http://cocrystalpharma.com/role/StatementsOfStockholdersEquity" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#StatementsOfCashFlows" roleURI="http://cocrystalpharma.com/role/StatementsOfCashFlows" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#CybersecurityRiskManagementAndStrategyDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/cyd/2025/cyd-2025.xsd#MaterialCybersecurityIncidentDisclosure" roleURI="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#OrganizationAndBusiness" roleURI="http://cocrystalpharma.com/role/OrganizationAndBusiness" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#BasisOfPresentationAndSignificantAccountingPolicies" roleURI="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ForeignCurrencyRemeasurement" roleURI="http://cocrystalpharma.com/role/ForeignCurrencyRemeasurement" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#PropertyAndEquipment" roleURI="http://cocrystalpharma.com/role/PropertyAndEquipment" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#AccountsPayableAndAccruedExpenses" roleURI="http://cocrystalpharma.com/role/AccountsPayableAndAccruedExpenses" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#CommonStock" roleURI="http://cocrystalpharma.com/role/CommonStock" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#StockBasedAwards" roleURI="http://cocrystalpharma.com/role/StockBasedAwards" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#Collaborations" roleURI="http://cocrystalpharma.com/role/Collaborations" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#IncomeTaxes" roleURI="http://cocrystalpharma.com/role/IncomeTaxes" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#LeaseCommitments" roleURI="http://cocrystalpharma.com/role/LeaseCommitments" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#TransactionsWithRelatedParties" roleURI="http://cocrystalpharma.com/role/TransactionsWithRelatedParties" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#SegmentInformation" roleURI="http://cocrystalpharma.com/role/SegmentInformation" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#BasisOfPresentationAndSignificantAccountingPoliciesPolicies" roleURI="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#BasisOfPresentationAndSignificantAccountingPoliciesTables" roleURI="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ForeignCurrencyRemeasurementTables" roleURI="http://cocrystalpharma.com/role/ForeignCurrencyRemeasurementTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#PropertyAndEquipmentTables" roleURI="http://cocrystalpharma.com/role/PropertyAndEquipmentTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#AccountsPayableAndAccruedExpensesTables" roleURI="http://cocrystalpharma.com/role/AccountsPayableAndAccruedExpensesTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#CommonStockTables" roleURI="http://cocrystalpharma.com/role/CommonStockTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#StockBasedAwardsTables" roleURI="http://cocrystalpharma.com/role/StockBasedAwardsTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#IncomeTaxesTables" roleURI="http://cocrystalpharma.com/role/IncomeTaxesTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#LeaseCommitmentsTables" roleURI="http://cocrystalpharma.com/role/LeaseCommitmentsTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#SegmentInformationTables" roleURI="http://cocrystalpharma.com/role/SegmentInformationTables" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#OrganizationAndBusinessDetailsNarrative" roleURI="http://cocrystalpharma.com/role/OrganizationAndBusinessDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" roleURI="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfReconciliationOfCashAndRestrictedCashDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfReconciliationOfCashAndRestrictedCashDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationsOfNetLossPerShareDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationsOfNetLossPerShareDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfCashBalanceDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfCashBalanceDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ForeignCurrencyRemeasurementDetailsNarrative" roleURI="http://cocrystalpharma.com/role/ForeignCurrencyRemeasurementDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfPropertyAndEquipmentDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfPropertyAndEquipmentDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#PropertyAndEquipmentDetailsNarrative" roleURI="http://cocrystalpharma.com/role/PropertyAndEquipmentDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfAccountsPayableAndAccruedExpensesDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfActivityOfWarrantsOutstandingDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfActivityOfWarrantsOutstandingDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#CommonStockDetailsNarrative" roleURI="http://cocrystalpharma.com/role/CommonStockDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfRoll-forwardOfCommonStockAvailableForFutureIssuanceDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfRoll-forwardOfCommonStockAvailableForFutureIssuanceDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfCommonStockAvailableForFutureIssuanceDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfCommonStockAvailableForFutureIssuanceDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfStockOptionTransactionsDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfStockOptionTransactionsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfRestrictedStockUnitsDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfRestrictedStockUnitsDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#StockBasedAwardsDetailsNarrative" roleURI="http://cocrystalpharma.com/role/StockBasedAwardsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#CollaborationsDetailsNarrative" roleURI="http://cocrystalpharma.com/role/CollaborationsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfIncomeLossBeforeProvisionBenefitForIncomeTaxesDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfIncomeLossBeforeProvisionBenefitForIncomeTaxesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#IncomeTaxesDetailsNarrative" roleURI="http://cocrystalpharma.com/role/IncomeTaxesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#LeaseCommitmentsDetailsNarrative" roleURI="http://cocrystalpharma.com/role/LeaseCommitmentsDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfComponentsOfRentExpenseAndSupplementalCashFlowInformationDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfComponentsOfRentExpenseAndSupplementalCashFlowInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfSupplementalBalanceSheetInformationDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfSupplementalBalanceSheetInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfSupplementalBalanceSheetInformationDetailsParenthetical" roleURI="http://cocrystalpharma.com/role/ScheduleOfSupplementalBalanceSheetInformationDetailsParenthetical" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#TransactionsWithRelatedPartiesDetailsNarrative" roleURI="http://cocrystalpharma.com/role/TransactionsWithRelatedPartiesDetailsNarrative" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#ScheduleOfSegmentInformationDetails" roleURI="http://cocrystalpharma.com/role/ScheduleOfSegmentInformationDetails" />
    <link:roleRef xlink:type="simple" xlink:href="cocp-20251231.xsd#SegmentInformationDetailsNarrative" roleURI="http://cocrystalpharma.com/role/SegmentInformationDetailsNarrative" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/BalanceSheets" xlink:title="00000002 - Statement - Consolidated Balance Sheets">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AssetsCurrent" xlink:label="loc_us-gaapAssetsCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Cash" xlink:label="loc_us-gaapCash" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapCash" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashCurrent" xlink:label="loc_us-gaapRestrictedCashCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapRestrictedCashCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ValueAddedTaxReceivableCurrent" xlink:label="loc_us-gaapValueAddedTaxReceivableCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapValueAddedTaxReceivableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:label="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssetsCurrent" xlink:to="loc_us-gaapPrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Assets" xlink:label="loc_us-gaapAssets" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapAssetsCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepositsAssetsNoncurrent" xlink:label="loc_us-gaapDepositsAssetsNoncurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapDepositsAssetsNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="loc_us-gaapOperatingLeaseRightOfUseAsset" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAssets" xlink:to="loc_us-gaapOperatingLeaseRightOfUseAsset" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesCurrent" xlink:label="loc_us-gaapLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesCurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesNoncurrent" xlink:label="loc_us-gaapLiabilitiesNoncurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesNoncurrent" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_Liabilities" xlink:label="loc_us-gaapLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilities" xlink:to="loc_us-gaapLiabilitiesNoncurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_StockholdersEquity" xlink:label="loc_us-gaapStockholdersEquity" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommonStockValue" xlink:label="loc_us-gaapCommonStockValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapCommonStockValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="loc_us-gaapAdditionalPaidInCapitalCommonStock" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapAdditionalPaidInCapitalCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="loc_us-gaapRetainedEarningsAccumulatedDeficit" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapStockholdersEquity" xlink:to="loc_us-gaapRetainedEarningsAccumulatedDeficit" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="loc_us-gaapLiabilitiesAndStockholdersEquity" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CommitmentsAndContingencies" xlink:label="loc_us-gaapCommitmentsAndContingencies" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapCommitmentsAndContingencies" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLiabilitiesAndStockholdersEquity" xlink:to="loc_us-gaapStockholdersEquity" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/BalanceSheetsParenthetical" xlink:title="00000003 - Statement - Consolidated Balance Sheets (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/StatementsOfOperations" xlink:title="00000004 - Statement - Consolidated Statements of Operations">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingExpenses" xlink:label="loc_us-gaapOperatingExpenses" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="loc_us-gaapResearchAndDevelopmentExpense" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapResearchAndDevelopmentExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="loc_us-gaapGeneralAndAdministrativeExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingExpenses" xlink:to="loc_us-gaapGeneralAndAdministrativeExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingIncomeLoss" xlink:label="loc_us-gaapOperatingIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingIncomeLoss" xlink:to="loc_us-gaapOperatingExpenses" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="loc_us-gaapNonoperatingIncomeExpense" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_InterestExpenseNonoperating" xlink:label="loc_us-gaapInterestExpenseNonoperating" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapInterestExpenseNonoperating" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:label="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNonoperatingIncomeExpense" xlink:to="loc_us-gaapForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapOperatingIncomeLoss" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetIncomeLoss" xlink:to="loc_us-gaapNonoperatingIncomeExpense" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/StatementsOfStockholdersEquity" xlink:title="00000005 - Statement - Consolidated Statements of Stockholders&apos; Equity" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/StatementsOfCashFlows" xlink:title="00000006 - Statement - Consolidated Statements of Cash Flows">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DepreciationAndAmortization" xlink:label="loc_us-gaapDepreciationAndAmortization" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapDepreciationAndAmortization" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cocp-20251231.xsd#COCP_RightOfUseAssetsRelatedToLeaseExpenses" xlink:label="loc_COCPRightOfUseAssetsRelatedToLeaseExpenses" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_COCPRightOfUseAssetsRelatedToLeaseExpenses" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ShareBasedCompensation" xlink:label="loc_us-gaapShareBasedCompensation" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapShareBasedCompensation" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cocp-20251231.xsd#COCP_ChangeInOperatingLeaseLiabilities" xlink:label="loc_COCPChangeInOperatingLeaseLiabilities" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_COCPChangeInOperatingLeaseLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInIncomeTaxesReceivable" xlink:label="loc_us-gaapIncreaseDecreaseInIncomeTaxesReceivable" />
      <link:calculationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInIncomeTaxesReceivable" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" />
      <link:calculationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInDepositOtherAssets" xlink:label="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" />
      <link:calculationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInDepositOtherAssets" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" />
      <link:calculationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:to="loc_us-gaapIncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:to="loc_us-gaapPaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:label="loc_us-gaapProceedsFromIssuanceOfCommonStock" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromIssuanceOfCommonStock" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_ProceedsFromOtherEquity" xlink:label="loc_us-gaapProceedsFromOtherEquity" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:to="loc_us-gaapProceedsFromOtherEquity" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInOperatingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInInvestingActivities" xlink:type="arc" weight="1" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="loc_us-gaapNetCashProvidedByUsedInFinancingActivities" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure" xlink:title="00000012 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/cyd/role/MaterialCybersecurityIncidentDisclosure" xlink:title="00000013 - Disclosure - Material Cybersecurity Incident Disclosure" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/OrganizationAndBusiness" xlink:title="999014 - Disclosure - Organization and Business" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPolicies" xlink:title="999015 - Disclosure - Basis of Presentation and Significant Accounting Policies" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ForeignCurrencyRemeasurement" xlink:title="999016 - Disclosure - Foreign Currency Remeasurement" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/PropertyAndEquipment" xlink:title="999017 - Disclosure - Property and Equipment" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/AccountsPayableAndAccruedExpenses" xlink:title="999018 - Disclosure - Accounts Payable and Accrued Expenses" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/CommonStock" xlink:title="999019 - Disclosure - Common Stock" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/StockBasedAwards" xlink:title="999020 - Disclosure - Stock Based Awards" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/Collaborations" xlink:title="999021 - Disclosure - Collaborations" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/IncomeTaxes" xlink:title="999022 - Disclosure - Income Taxes" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/LeaseCommitments" xlink:title="999023 - Disclosure - Lease Commitments" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/TransactionsWithRelatedParties" xlink:title="999024 - Disclosure - Transactions with Related Parties" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/SegmentInformation" xlink:title="999025 - Disclosure - Segment information" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPoliciesPolicies" xlink:title="999026 - Disclosure - Basis of Presentation and Significant Accounting Policies (Policies)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPoliciesTables" xlink:title="999027 - Disclosure - Basis of Presentation and Significant Accounting Policies (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ForeignCurrencyRemeasurementTables" xlink:title="999028 - Disclosure - Foreign Currency Remeasurement (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/PropertyAndEquipmentTables" xlink:title="999029 - Disclosure - Property and Equipment (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/AccountsPayableAndAccruedExpensesTables" xlink:title="999030 - Disclosure - Accounts Payable and Accrued Expenses (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/CommonStockTables" xlink:title="999031 - Disclosure - Common Stock (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/StockBasedAwardsTables" xlink:title="999032 - Disclosure - Stock Based Awards (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/IncomeTaxesTables" xlink:title="999033 - Disclosure - Income Taxes (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/LeaseCommitmentsTables" xlink:title="999034 - Disclosure - Lease Commitments (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/SegmentInformationTables" xlink:title="999035 - Disclosure - Segment information (Tables)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/OrganizationAndBusinessDetailsNarrative" xlink:title="999036 - Disclosure - Organization and Business (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/BasisOfPresentationAndSignificantAccountingPoliciesDetailsNarrative" xlink:title="999037 - Disclosure - Basis of Presentation and Significant Accounting Policies (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfReconciliationOfCashAndRestrictedCashDetails" xlink:title="999038 - Disclosure - Schedule of Reconciliation of Cash and Restricted Cash (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="loc_us-gaapCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_RestrictedCashAndCashEquivalentsAtCarryingValue" xlink:label="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="loc_us-gaapRestrictedCashAndCashEquivalentsAtCarryingValue" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfAnti-dilutiveSecuritiesExcludedFromCalculationsOfNetLossPerShareDetails" xlink:title="999039 - Disclosure - Schedule of Anti-dilutive Securities Excluded from Calculations of Net Loss Per Share (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfCashBalanceDetails" xlink:title="999040 - Disclosure - Schedule of Cash Balance (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ForeignCurrencyRemeasurementDetailsNarrative" xlink:title="999041 - Disclosure - Foreign Currency Remeasurement (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfPropertyAndEquipmentDetails" xlink:title="999042 - Disclosure - Schedule of Property and Equipment (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="loc_us-gaapPropertyPlantAndEquipmentNet" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="loc_us-gaapPropertyPlantAndEquipmentGross" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapPropertyPlantAndEquipmentGross" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapPropertyPlantAndEquipmentNet" xlink:to="loc_us-gaapAccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" weight="-1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/PropertyAndEquipmentDetailsNarrative" xlink:title="999043 - Disclosure - Property and Equipment (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" xlink:title="999044 - Disclosure - Schedule of Accounts Payable and Accrued Expenses (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_AccountsPayableCurrent" xlink:label="loc_us-gaapAccountsPayableCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapAccountsPayableCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapEmployeeRelatedLiabilitiesCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="loc_us-gaapOtherAccruedLiabilitiesCurrent" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapAccountsPayableAndAccruedLiabilitiesCurrent" xlink:to="loc_us-gaapOtherAccruedLiabilitiesCurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfActivityOfWarrantsOutstandingDetails" xlink:title="999045 - Disclosure - Schedule of Activity of Warrants Outstanding (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/CommonStockDetailsNarrative" xlink:title="999046 - Disclosure - Common Stock (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfRoll-forwardOfCommonStockAvailableForFutureIssuanceDetails" xlink:title="999047 - Disclosure - Schedule of Roll-forward of Common Stock Available for Future Issuance (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfCommonStockAvailableForFutureIssuanceDetails" xlink:title="999048 - Disclosure - Schedule of Common Stock Available for Future Issuance (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfStockOptionTransactionsDetails" xlink:title="999049 - Disclosure - Schedule of Stock Option Transactions (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfRestrictedStockUnitsDetails" xlink:title="999050 - Disclosure - Schedule of Restricted Stock Units (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/StockBasedAwardsDetailsNarrative" xlink:title="999051 - Disclosure - Stock Based Awards (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/CollaborationsDetailsNarrative" xlink:title="999052 - Disclosure - Collaborations (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfIncomeLossBeforeProvisionBenefitForIncomeTaxesDetails" xlink:title="999053 - Disclosure - Schedule of Income (Loss) Before Provision (Benefit) for Income Taxes (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:label="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="loc_us-gaapIncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="999054 - Disclosure - Schedule of Deferred Tax Assets and Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="loc_us-gaapDeferredTaxAssetsGross" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:label="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpense" xlink:label="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxDeferredExpense" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cocp-20251231.xsd#COCP_DeferredTaxAssetsCapitalizedAndResearchExpenditures" xlink:label="loc_COCPDeferredTaxAssetsCapitalizedAndResearchExpenditures" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_COCPDeferredTaxAssetsCapitalizedAndResearchExpenditures" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsOther" xlink:label="loc_us-gaapDeferredTaxAssetsOther" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsGross" xlink:to="loc_us-gaapDeferredTaxAssetsOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredIncomeTaxLiabilities" xlink:label="loc_us-gaapDeferredIncomeTaxLiabilities" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:label="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilitiesOther" xlink:label="loc_us-gaapDeferredTaxLiabilitiesOther" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxLiabilitiesOther" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="loc_us-gaapDeferredTaxAssetsNet" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredTaxAssetsGross" xlink:type="arc" weight="1" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxAssetsNet" xlink:to="loc_us-gaapDeferredIncomeTaxLiabilities" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="loc_us-gaapDeferredTaxLiabilities" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsNet" xlink:type="arc" weight="-1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="loc_us-gaapDeferredTaxAssetsValuationAllowance" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapDeferredTaxLiabilities" xlink:to="loc_us-gaapDeferredTaxAssetsValuationAllowance" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfReconciliationOfFederalStatutoryIncomeTaxRateDetails" xlink:title="999055 - Disclosure - Schedule of Reconciliation of Federal Statutory Income Tax Rate (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/IncomeTaxesDetailsNarrative" xlink:title="999056 - Disclosure - Income Taxes (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/LeaseCommitmentsDetailsNarrative" xlink:title="999057 - Disclosure - Lease Commitments (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfComponentsOfRentExpenseAndSupplementalCashFlowInformationDetails" xlink:title="999058 - Disclosure - Schedule of Components of Rent Expense and Supplemental Cash Flow Information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfSupplementalBalanceSheetInformationDetails" xlink:title="999059 - Disclosure - Schedule of Supplemental Balance Sheet Information (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiability" xlink:label="loc_us-gaapOperatingLeaseLiability" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityCurrent" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeaseLiability" xlink:to="loc_us-gaapOperatingLeaseLiabilityCurrent" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="loc_us-gaapOperatingLeaseLiabilityNoncurrent" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapOperatingLeaseLiability" xlink:to="loc_us-gaapOperatingLeaseLiabilityNoncurrent" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfSupplementalBalanceSheetInformationDetailsParenthetical" xlink:title="999060 - Disclosure - Schedule of Supplemental Balance Sheet Information (Details) (Parenthetical)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfMaturitiesOfLeaseLiabilitiesDetails" xlink:title="999061 - Disclosure - Schedule of Maturities of Lease Liabilities (Details)">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" />
      <link:calculationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" />
      <link:calculationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" />
      <link:calculationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2025/elts/us-gaap-2025.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" />
      <link:calculationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" weight="1" />
      <link:loc xlink:type="locator" xlink:href="cocp-20251231.xsd#COCP_LesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" xlink:label="loc_COCPLesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" />
      <link:calculationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaapLesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="loc_COCPLesseeOperatingLeaseLiabilityPaymentsDueYearFiveAndThereAfter" xlink:type="arc" weight="1" />
    </link:calculationLink>
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/TransactionsWithRelatedPartiesDetailsNarrative" xlink:title="999062 - Disclosure - Transactions with Related Parties (Details Narrative)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/ScheduleOfSegmentInformationDetails" xlink:title="999063 - Disclosure - Schedule of Segment Information (Details)" />
    <link:calculationLink xlink:type="extended" xlink:role="http://cocrystalpharma.com/role/SegmentInformationDetailsNarrative" xlink:title="999064 - Disclosure - Segment information (Details Narrative)" />
</link:linkbase>
